Week in Review: March 17 - Insights
Today's Highlights Include: Rochester public schools receives grant to support youth mental health, and FDA releases new regs intended to help detect breast cancer sooner.
Mission not impossible: Overcoming challenging pediatric draws - Insights
This “Phlebotomy Webinar” covers real-life challenging scenarios that arise in the clinical setting. Four unique case studies are presented, and suggestions are discussed on how to help and respond in these situations to support the...
This “phlebotomy webinar” will walk learners through the quality improvement methodology and describe PDSA cycle interventions that were implemented in this unit which successfully reduced the amount of canceled labs due to specimen...
Annual screening for latent tuberculosis in healthcare workers: No longer required - Insights
This "Phlebotomy Webinar" presentation will review the methods available to detect latent infection with Mycobacterium tuberculosis, or latent tuberculosis infection (LTBI), including the classic tuberculin skin test and the more recently...
How lab innovation drives revenue and accelerates growth - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, recently shared with the Advisory Board his insight into the potential that digital pathology and out-of-lab testing can bring into the...
A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than...
Establishing a trusted lab partner in an evolving landscape - Insights
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, authored a Becker’s Healthcare article on how hospital laboratories can navigate times of change and uncertainty with the steadfast support...
Dr. Matt Binnicker sheds light on new Arcturus COVID-19 variant - Insights
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”
Domestic Logistics Impacts: Independence Day Holiday Weekend - Insights
Due to the upcoming Independence Day holiday on Tuesday, July 4, Mayo Clinic Laboratories' sample pickup and delivery schedules will be altered. To ensure sample viability and minimize test turnaround time delays, we have implemented...
Memorial Day Specimen Shipment Alert - Insights
Due to the Memorial Day holiday (recognized on Monday, May 29), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan...